NIH-funded research R01 grant

Investigating how TMX1 protein affects blood clotting

Official title: The Transmembrane Protein Disulfide Isomerase TMX1 Negatively Regulates Thrombosis

Funded at Temple Univ of the Commonwealth · NIH-11011322 · Data updated 2026-11-12

This study is looking at a protein called TMX1 to see how it helps control blood clotting and platelet function, which could lead to better treatments for people with conditions like heart problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTemple Univ of the Commonwealth
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJanuary 15, 2023
Project endDecember 31, 2026
Funding year2025
Award (this year)$621,245
NIH project number5R01HL162845-03
Project IDNIH-11011322 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a history of acute coronary syndrome or other thrombotic conditions.

Less likely to help

Patients who do not have issues related to blood clotting or thrombosis may not receive any benefit from this research.

What this research studies

This research focuses on understanding the role of the TMX1 protein in regulating blood clotting and platelet function. It aims to explore how TMX1 acts as a negative regulator of platelet activation and coagulation, which is crucial in conditions like acute coronary syndrome. The study will involve characterizing the mechanisms by which TMX1 influences these processes, potentially leading to new therapeutic strategies for managing thrombosis. Patients may benefit from insights gained about how to better control blood clotting in various medical conditions.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients at risk of thrombosis, reducing complications from conditions like acute coronary syndrome.

How similar studies have gone: Previous research has shown success in targeting platelet activation and coagulation pathways, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Temple Univ of the Commonwealth
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Essex, David W — Temple Univ of the Commonwealth
  • Study coordinator: Essex, David W

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.